Catalyst Wire Dossier Catalyst Wire Dossier

bupivacaine liposome injectable suspension

bupivacaine liposome injectable suspension
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bupivacaine liposome injectable suspension, covering 2025-05-15 to 2025-05-15. Get the full timeline:

Most recent: Clinical Trial Update: Determination of the Optimal Volume of 0.5% Bupivacaine Liposome in Single-Injection Interscalene Brachial Plexus Block: A Bayesian Phase I/II Trial

See pricing